Navigation Links
Pharsight Announces 1-For-3 Reverse Stock Split
Date:11/13/2007

g statements regarding listing of Pharsight's common stock on the Nasdaq Capital Market, Pharsight's growth strategies and opportunities, Pharsight's valuation and the effectiveness of Pharsight's reverse stock split. These forward-looking statements involve risks and uncertainties, and factors that could cause actual results to differ materially include the following: changes in the demand for Pharsight's products and services; changes in Pharsight's operating strategies, pricing models or research and development focus; the failure to develop new products and services or to keep pace with technological changes; the failure of the market for Pharsight's products and services to develop as expected; the failure to generate additional sales from existing customers or to generate sales to new customers; the failure to meet customers' expectations; uncertainties involved in pharmaceutical drug development; changes in government regulation of the pharmaceutical industry; and uncertainties regarding the listing of our common stock on the Nasdaq Capital Market. There can be no assurance that Pharsight's common stock will be listed on the Nasdaq Capital Market. Further information on potential factors that could affect actual results is included in Pharsight's Quarterly Report on Form 10-Q, as filed with the Securities and Exchange Commission on November 9, 2007. All forward-looking statements are based on information available to Pharsight as of the date hereof, and Pharsight assumes no obligation to update such statements, whether as a result of new developments or otherwise.


'/>"/>
SOURCE Pharsight Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pharsight Achieves First License Sale for Public-Source Database
2. Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007
3. Pharsight Expands Strategic Consulting Services Team
4. Pharsight Hosts Fourth Annual PKS User Group Meeting
5. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
6. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ... the appointment of Dr. Alan Warrander to the ... Business Development. ,, "Dr. Warrander will be responsible ... for REOLYSIN(R)," said Dr. Brad Thompson, President and ... the design of a Phase 3 trial examining ...
(Date:12/10/2009)... Inc. (Nasdaq: ELGX ), developer of minimally ... Dan Lemaitre, former President and CEO of CoreValve, ... December 11, 2009. Endologix now has four ... D. Brown, Chairman of the Board, said, "We ... Endologix Board of Directors. He has a ...
(Date:12/10/2009)... - YM BioSciences Inc. (NYSE Amex: YMI ... company that identifies and advances a diverse portfolio ... development, today provided an update on the proposed ... Cytopia Ltd. into YM, details of which were ... directors of Cytopia has unanimously recommended that its ...
(Date:12/10/2009)... 10 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc.,(OTC Bulletin ... growing developer and,producer of prescription drugs and ... People,s Republic of China ("PRC"), today reported ... controlled operating entity of Lotus,appointed Mr. Jinzhong ... Company,s,Over-the-Counter Drug division ("OTC Division"). , ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Endologix Appoints Dan Lemaitre to its Board of Directors 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3
... , , ... , , , , ... protein from human melanoma cell lines [1]. MIA,is expressed in and ... chondrocytes,is dependent on the differentiation status of the cells,it was also ...
... , , , ... , Abstract , ... The efficiency of the Rapid DNA Ligation Kit from,Roche Molecular ... DNA in a three-fragment assembly,DNA ligation. Sequential blunt-end and cohesive-end,ligation, including a temperature ...
... , ... , , Roche Applied Science was ... move away from the use of hazardous,radioactive isotopes. Even after 15 ... technologies, the,DIG System remains THE nonradioactive technology of,choice to label and ...
Other Biology Technology:Quantitation of the Protein MIA as a Marker for,Chondrocytes in Research Samples 2Quantitation of the Protein MIA as a Marker for,Chondrocytes in Research Samples 3Cloning Based on Efficient Three-Fragment Assembly,DNA Ligation 2Cloning Based on Efficient Three-Fragment Assembly,DNA Ligation 3Cloning Based on Efficient Three-Fragment Assembly,DNA Ligation 4The DIG System Nonradioactive and,Highly Sensitive Detection of Nucleic Acids 2The DIG System Nonradioactive and,Highly Sensitive Detection of Nucleic Acids 3The DIG System Nonradioactive and,Highly Sensitive Detection of Nucleic Acids 4The DIG System Nonradioactive and,Highly Sensitive Detection of Nucleic Acids 5
(Date:12/11/2009)... studying how bacteria under stress collectively weigh and initiate ... into how humans make strategic decisions that affect their ... , Their study, published this week in the early ... National Academy of Sciences , was accomplished when the ... describe the complex interplay of genes and proteins that ...
(Date:12/11/2009)... New discoveries about the deep ocean,s temperature variability and ... conditions. , The deep ocean is affected more by ... for more accurate predictions of factors such as sea ... surface temperatures have also been found to result in ... results in a faster transport of large quantities of ...
(Date:12/11/2009)... is a health risk but why do teens become ... evaluation for Faculty of 1000 Biology, Neil Grunberg looks ... , Grunberg describes the study, published by Natividad et ... suggests it "may have implications to help understand why ... increases the level of dopamine in the brain, a ...
Breaking Biology News(10 mins):Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5New discoveries could improve climate projections 2TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 1TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 2TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 3TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 4Swine Flu Loves a Crowd 57482 1Swine Flu Loves a Crowd 57482 2Swine Flu Loves a Crowd 57482 3Swine Flu Loves a Crowd 57482 4Valeant Pharmaceuticals to Present at the UBS Global Life Sciences Conference 57478 1Valeant Pharmaceuticals to Present at the UBS Global Life Sciences Conference 57478 2
... In order to increase productivity, forest practices have become ... 800% in the southeastern United States from 1990 to ... exceeds the forest area fertilized in the rest of ... practices, including fertilization, may negatively impact water quality in ...
... a host of threats that can result in fetal/neonatal ... issue of the American Journal of Obstetrics & Gynecology, ... the Drexel University College of Medicine found that genital ... 23% of neonates born between 23 and 32 weeks ...
... identified a key factor that determines the ability of ... respiratory tracta necessary step for sustaining spread between people. ... of Nature Biotechnology and funded by the National Institutes ... H5N1 avian flu virus currently circulating in birds would ...
Other Biology News:Will intensive forest practices impact water quality? 2Bacterial infections in premature babies more common than previously realized 2Study of sugars on cell surface identifies key factor in flu infection 2Study of sugars on cell surface identifies key factor in flu infection 3
Maxi 14 Hybridization Oven. 14 bottle (35 mm) rotisserie + shaker tray available for simultaneous use. Includes linear and orbital shaker trays, 4 medium bottles, pack of mesh, bottle gripper and d...
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
... Expansion Kit - Monolayer Plus is a system ... as a monolayer in a serum-free environment. The ... Supplement, which has been optimized for neural stem ... (1996) Genes & Development 10 :3129). Human ...
... DNase is a preparation of deoxyribonuclease ... DNA to produce 3-hydroxyl oligonucleotides. This ... applications where maintaining the integrity of ... qualified for use with the Core ...
Biology Products: